25 XP   0   0   10

Reneo Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Reneo Pharmaceuticals Inc together

PenkeI guess you are interested in Reneo Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Reneo Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Reneo Pharmaceuticals Inc

I send you an email if I find something interesting about Reneo Pharmaceuticals Inc.

Quick analysis of Reneo Pharmaceuticals Inc (30 sec.)










What can you expect buying and holding a share of Reneo Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.65
Expected worth in 1 year
$2.30
How sure are you?
15.4%

+ What do you gain per year?

Total Gains per Share
$-0.35
Return On Investment
-21.1%

For what price can you sell your share?

Current Price per Share
$1.66
Expected price per share
$1.565 - $1.79
How sure are you?
50%

1. Valuation of Reneo Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)

$1.66

Intrinsic Value Per Share

$-31.22 - $-36.97

Total Value Per Share

$-28.57 - $-34.31

2. Growth of Reneo Pharmaceuticals Inc (5 min.)




Is Reneo Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$88.6m$117.8m-$12m-11.4%

How much money is Reneo Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$19m-$12.5m-$6.5m-34.4%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Reneo Pharmaceuticals Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#398 / 1019

Most Revenue
#849 / 1019

Most Profit
#687 / 1019

Most Efficient
#311 / 1019

What can you expect buying and holding a share of Reneo Pharmaceuticals Inc? (5 min.)

Welcome investor! Reneo Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Reneo Pharmaceuticals Inc.

What can you expect buying and holding a share of Reneo Pharmaceuticals Inc?

First you should know what it really means to hold a share of Reneo Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Reneo Pharmaceuticals Inc is $1.66. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Reneo Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Reneo Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.65. Based on the TTM, the Book Value Change Per Share is $-0.09 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.35 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Reneo Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.70-42.5%-0.58-34.8%-0.39-23.5%-0.40-24.3%-0.40-24.3%
Usd Book Value Change Per Share-0.75-45.1%-0.09-5.3%-0.35-21.4%0.2012.3%0.2012.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.75-45.1%-0.09-5.3%-0.35-21.4%0.2012.3%0.2012.3%
Usd Price Per Share1.60-5.44-2.82-4.49-4.49-
Price to Earnings Ratio-0.57--2.50--1.81--2.87--2.87-
Price-to-Total Gains Ratio-2.14--6.49--7.95--9.99--9.99-
Price to Book Ratio0.60-1.69-0.80-1.18-1.18-
Price-to-Total Gains Ratio-2.14--6.49--7.95--9.99--9.99-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.66
Number of shares602
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.090.20
Usd Total Gains Per Share-0.090.20
Gains per Quarter (602 shares)-52.63122.78
Gains per Year (602 shares)-210.52491.11
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-211-2210491481
20-421-4320982972
30-632-643014731463
40-842-854019641954
50-1053-1065024562445
60-1263-1276029472936
70-1474-1487034383427
80-1684-1698039293918
90-1895-1909044204409
100-2105-2120049114900

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.013.00.00.0%0.013.00.00.0%0.013.00.00.0%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%2.011.00.015.4%2.011.00.015.4%2.011.00.015.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.013.00.0%0.00.013.00.0%0.00.013.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%2.011.00.015.4%2.011.00.015.4%2.011.00.015.4%

Fundamentals of Reneo Pharmaceuticals Inc

About Reneo Pharmaceuticals Inc

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. Its lead product candidate is REN001, a potent and selective agonist of the peroxisome proliferator-activated receptor delta that is in clinical development for genetic mitochondrial diseases comprising primary mitochondrial myopathies and long-chain fatty acid oxidation disorders. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Irvine, California.

Fundamental data was last updated by Penke on 2024-04-12 17:00:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Reneo Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Reneo Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Reneo Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Reneo Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--196.9%+196.9%
TTM--211.2%+211.2%
YOY--279.3%+279.3%
5Y--436.8%+436.8%
10Y--599.3%+599.3%
1.1.2. Return on Assets

Shows how efficient Reneo Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Reneo Pharmaceuticals Inc to the Biotechnology industry mean.
  • -21.9% Return on Assets means that Reneo Pharmaceuticals Inc generated $-0.22 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Reneo Pharmaceuticals Inc:

  • The MRQ is -21.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -16.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-21.9%TTM-16.0%-5.9%
TTM-16.0%YOY-9.9%-6.1%
TTM-16.0%5Y-11.0%-5.0%
5Y-11.0%10Y-11.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.9%-13.6%-8.3%
TTM-16.0%-12.9%-3.1%
YOY-9.9%-11.9%+2.0%
5Y-11.0%-14.2%+3.2%
10Y-11.0%-16.2%+5.2%
1.1.3. Return on Equity

Shows how efficient Reneo Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Reneo Pharmaceuticals Inc to the Biotechnology industry mean.
  • -26.6% Return on Equity means Reneo Pharmaceuticals Inc generated $-0.27 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Reneo Pharmaceuticals Inc:

  • The MRQ is -26.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -18.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-26.6%TTM-18.6%-8.0%
TTM-18.6%YOY-10.7%-7.8%
TTM-18.6%5Y-10.6%-7.9%
5Y-10.6%10Y-10.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-26.6%-17.0%-9.6%
TTM-18.6%-16.1%-2.5%
YOY-10.7%-15.4%+4.7%
5Y-10.6%-20.0%+9.4%
10Y-10.6%-21.1%+10.5%

1.2. Operating Efficiency of Reneo Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Reneo Pharmaceuticals Inc is operating .

  • Measures how much profit Reneo Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Reneo Pharmaceuticals Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Reneo Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--282.4%+282.4%
TTM--225.8%+225.8%
YOY--288.4%+288.4%
5Y--475.2%+475.2%
10Y--624.7%+624.7%
1.2.2. Operating Ratio

Measures how efficient Reneo Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Reneo Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.994-2.994
TTM-3.247-3.247
YOY-3.766-3.766
5Y-5.675-5.675
10Y-7.857-7.857

1.3. Liquidity of Reneo Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Reneo Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.87 means the company has $5.87 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Reneo Pharmaceuticals Inc:

  • The MRQ is 5.866. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.817. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.866TTM8.817-2.951
TTM8.817YOY15.403-6.586
TTM8.8175Y18.030-9.214
5Y18.03010Y18.0300.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.8663.930+1.936
TTM8.8174.251+4.566
YOY15.4035.436+9.967
5Y18.0306.045+11.985
10Y18.0306.383+11.647
1.3.2. Quick Ratio

Measures if Reneo Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Reneo Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Quick Ratio of 4.14 means the company can pay off $4.14 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Reneo Pharmaceuticals Inc:

  • The MRQ is 4.144. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 14.227. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.144TTM14.227-10.083
TTM14.227YOY19.900-5.673
TTM14.2275Y22.073-7.846
5Y22.07310Y22.0730.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1443.629+0.515
TTM14.2274.065+10.162
YOY19.9005.390+14.510
5Y22.0735.993+16.080
10Y22.0736.277+15.796

1.4. Solvency of Reneo Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Reneo Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Reneo Pharmaceuticals Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.18 means that Reneo Pharmaceuticals Inc assets are financed with 17.5% credit (debt) and the remaining percentage (100% - 17.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Reneo Pharmaceuticals Inc:

  • The MRQ is 0.175. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.129. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.175TTM0.129+0.046
TTM0.129YOY0.074+0.056
TTM0.1295Y0.323-0.193
5Y0.32310Y0.3230.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1750.332-0.157
TTM0.1290.333-0.204
YOY0.0740.268-0.194
5Y0.3230.366-0.043
10Y0.3230.390-0.067
1.4.2. Debt to Equity Ratio

Measures if Reneo Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Reneo Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 21.2% means that company has $0.21 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Reneo Pharmaceuticals Inc:

  • The MRQ is 0.212. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.150. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.212TTM0.150+0.063
TTM0.150YOY0.080+0.070
TTM0.1505Y0.079+0.071
5Y0.07910Y0.0790.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2120.380-0.168
TTM0.1500.389-0.239
YOY0.0800.334-0.254
5Y0.0790.432-0.353
10Y0.0790.465-0.386

2. Market Valuation of Reneo Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Reneo Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Reneo Pharmaceuticals Inc to the Biotechnology industry mean.
  • A PE ratio of -0.57 means the investor is paying $-0.57 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Reneo Pharmaceuticals Inc:

  • The EOD is -0.589. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.568. Based on the earnings, the company is expensive. -2
  • The TTM is -2.504. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.589MRQ-0.568-0.021
MRQ-0.568TTM-2.504+1.936
TTM-2.504YOY-1.811-0.693
TTM-2.5045Y-2.867+0.364
5Y-2.86710Y-2.8670.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.589-2.426+1.837
MRQ-0.568-2.552+1.984
TTM-2.504-2.656+0.152
YOY-1.811-4.143+2.332
5Y-2.867-6.252+3.385
10Y-2.867-6.108+3.241
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Reneo Pharmaceuticals Inc:

  • The EOD is -0.701. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.676. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.223. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.701MRQ-0.676-0.025
MRQ-0.676TTM-3.223+2.547
TTM-3.223YOY-2.088-1.135
TTM-3.2235Y-3.281+0.058
5Y-3.28110Y-3.2810.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.701-3.199+2.498
MRQ-0.676-3.259+2.583
TTM-3.223-3.552+0.329
YOY-2.088-5.617+3.529
5Y-3.281-8.326+5.045
10Y-3.281-8.689+5.408
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Reneo Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.60 means the investor is paying $0.60 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Reneo Pharmaceuticals Inc:

  • The EOD is 0.626. Based on the equity, the company is cheap. +2
  • The MRQ is 0.603. Based on the equity, the company is cheap. +2
  • The TTM is 1.695. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.626MRQ0.603+0.023
MRQ0.603TTM1.695-1.091
TTM1.695YOY0.802+0.893
TTM1.6955Y1.182+0.513
5Y1.18210Y1.1820.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.6261.947-1.321
MRQ0.6032.116-1.513
TTM1.6952.095-0.400
YOY0.8022.836-2.034
5Y1.1823.443-2.261
10Y1.1823.791-2.609
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Reneo Pharmaceuticals Inc.

3.1. Institutions holding Reneo Pharmaceuticals Inc

Institutions are holding 82.414% of the shares of Reneo Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31NEA Management Company, LLC14.36580.5103478549400
2023-12-31The Carlyle Group Inc8.10210.2077269895700
2023-12-31RiverVest Venture Management LLC7.607614.9515253422000
2023-09-30Octagon Capital Advisors LP6.8442.66732279870-88717-3.7456
2023-12-31BML Capital Management LLC3.94521.5927131422913142290
2023-12-31Highbridge Capital Management, LLC3.36730.0732112170411217040
2023-12-31BlackRock Inc2.9518098330436448458.8998
2023-12-31Vanguard Group Inc2.9386097888937420.3837
2023-12-31Aisling Capital Management LP2.65990.422988607500
2023-12-31Rock Springs Capital Management LP2.25660.0296751730-391455-34.2425
2023-12-31Ikarian Capital, LLC1.26470.06314213004213000
2023-12-31Renaissance Technologies Corp1.2020.0014004003644001012.2222
2023-12-31Vestal Point Capital LP1.20080.06784000004000000
2023-12-31Geode Capital Management, LLC1.01930.000133954189122.6955
2023-12-31State Street Corporation0.742802474302939313.4807
2023-12-31Two Sigma Investments LLC0.54780.00071824741824740
2023-12-31Millennium Management LLC0.4770.00011588903620529.5105
2023-12-31Goldman Sachs Group Inc0.389012957287261206.2371
2023-12-31Morgan Stanley - Brokerage Accounts0.375012492592607286.5493
2023-12-31BOOTHBAY FUND MANAGEMENT, LLC0.35910.00491196251196250
Total 62.616420.592920858629+4066164+19.5%

3.2. Funds holding Reneo Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv1.78370.000159611300
2024-03-28iShares Russell 2000 ETF1.36850.00124573602220.0486
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.83340.000527854100
2024-03-28iShares Biotechnology ETF0.59170.004319774200
2024-01-31Fidelity Small Cap Index0.38740.000912947500
2024-02-29Fidelity Extended Market Index0.28880.000496534-468-0.4825
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.24050.00038039300
2023-12-31Bridgeway Ultra-Small Company Market0.22590.0657550000
2024-03-28iShares Russell 2000 Growth ETF0.21250.00171014-83-0.1167
2023-09-30Federated Hermes Prudent Bear A0.17950.21866000000
2024-02-29Vanguard Russell 2000 ETF0.13990.00084675935608.2409
2023-09-30BlackRock Extended Mkt Composite0.13640.0025455872670.5891
2024-02-29Fidelity Total Market Index0.10850.00013625700
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.10560.00063530000
2023-12-31NT R2000 Index Fund - NL0.10540.000835223-3143-8.1921
2024-02-29Schwab Small Cap Index0.090.00083007800
2023-12-31NT R2000 Index Fund - DC - NL - 20.0830.000827739-2592-8.5457
2024-03-28iShares Micro-Cap ETF0.08240.0052753900
2023-12-31NT R2000 Growth Index Fund - NL0.07780.00112600500
2024-02-29Fidelity Series Total Market Index0.07620.00012546800
Total 7.11710.30492378627-2237-0.1%

3.3. Insider Transactions

Insiders are holding 3.014% of the shares of Reneo Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-08-28Ashley HallSELL156256.28
2023-06-23Holdings A/s NovoSELL1000007.1
2023-05-08Niall O'donnellBUY1250008

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Reneo Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.749-0.087-88%-0.355-53%0.204-467%0.204-467%
Book Value Per Share--2.6513.161-16%3.538-25%2.939-10%2.939-10%
Current Ratio--5.8668.817-33%15.403-62%18.030-67%18.030-67%
Debt To Asset Ratio--0.1750.129+35%0.074+138%0.323-46%0.323-46%
Debt To Equity Ratio--0.2120.150+42%0.080+167%0.079+168%0.079+168%
Dividend Per Share----0%-0%-0%-0%
Eps---0.705-0.578-18%-0.390-45%-0.404-43%-0.404-43%
Free Cash Flow Per Share---0.592-0.477-19%-0.358-39%-0.358-40%-0.358-40%
Free Cash Flow To Equity Per Share---0.715-0.020-97%-0.355-50%0.199-460%0.199-460%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---36.965--------
Intrinsic Value_10Y_min---31.225--------
Intrinsic Value_1Y_max---1.818--------
Intrinsic Value_1Y_min---1.784--------
Intrinsic Value_3Y_max---6.899--------
Intrinsic Value_3Y_min---6.558--------
Intrinsic Value_5Y_max---13.714--------
Intrinsic Value_5Y_min---12.605--------
Market Cap55297588.000+3%53473292.800182162691.494-71%93855996.500-43%149835588.152-64%149835588.152-64%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.626+4%0.6031.695-64%0.802-25%1.182-49%1.182-49%
Pe Ratio-0.589-4%-0.568-2.504+341%-1.811+219%-2.867+405%-2.867+405%
Price Per Share1.660+4%1.6005.439-71%2.818-43%4.489-64%4.489-64%
Price To Free Cash Flow Ratio-0.701-4%-0.676-3.223+377%-2.088+209%-3.281+385%-3.281+385%
Price To Total Gains Ratio-2.218-4%-2.137-6.488+204%-7.946+272%-9.985+367%-9.985+367%
Quick Ratio--4.14414.227-71%19.900-79%22.073-81%22.073-81%
Return On Assets---0.219-0.160-27%-0.099-55%-0.110-50%-0.110-50%
Return On Equity---0.266-0.186-30%-0.107-60%-0.106-60%-0.106-60%
Total Gains Per Share---0.749-0.087-88%-0.355-53%0.204-467%0.204-467%
Usd Book Value--88610000.000105791500.000-16%117872500.000-25%98061076.923-10%98061076.923-10%
Usd Book Value Change Per Share---0.749-0.087-88%-0.355-53%0.204-467%0.204-467%
Usd Book Value Per Share--2.6513.161-16%3.538-25%2.939-10%2.939-10%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.705-0.578-18%-0.390-45%-0.404-43%-0.404-43%
Usd Free Cash Flow---19778000.000-15975750.000-19%-11927000.000-40%-11939923.077-40%-11939923.077-40%
Usd Free Cash Flow Per Share---0.592-0.477-19%-0.358-39%-0.358-40%-0.358-40%
Usd Free Cash Flow To Equity Per Share---0.715-0.020-97%-0.355-50%0.199-460%0.199-460%
Usd Market Cap55297588.000+3%53473292.800182162691.494-71%93855996.500-43%149835588.152-64%149835588.152-64%
Usd Price Per Share1.660+4%1.6005.439-71%2.818-43%4.489-64%4.489-64%
Usd Profit---23554000.000-19093000.000-19%-12515500.000-47%-13265923.077-44%-13265923.077-44%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.749-0.087-88%-0.355-53%0.204-467%0.204-467%
 EOD+5 -3MRQTTM+3 -26YOY+3 -265Y+4 -2510Y+4 -25

4.2. Fundamental Score

Let's check the fundamental score of Reneo Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.589
Price to Book Ratio (EOD)Between0-10.626
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.144
Current Ratio (MRQ)Greater than15.866
Debt to Asset Ratio (MRQ)Less than10.175
Debt to Equity Ratio (MRQ)Less than10.212
Return on Equity (MRQ)Greater than0.15-0.266
Return on Assets (MRQ)Greater than0.05-0.219
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Reneo Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.495
Ma 20Greater thanMa 501.684
Ma 50Greater thanMa 1001.658
Ma 100Greater thanMa 2002.480
OpenGreater thanClose1.710
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets107,436
Total Liabilities18,826
Total Stockholder Equity88,610
 As reported
Total Liabilities 18,826
Total Stockholder Equity+ 88,610
Total Assets = 107,436

Assets

Total Assets107,436
Total Current Assets106,622
Long-term Assets814
Total Current Assets
Cash And Cash Equivalents 27,632
Short-term Investments 75,331
Other Current Assets 3,659
Total Current Assets  (as reported)106,622
Total Current Assets  (calculated)106,622
+/-0
Long-term Assets
Property Plant Equipment 733
Long-term Assets Other 81
Long-term Assets  (as reported)814
Long-term Assets  (calculated)814
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities18,177
Long-term Liabilities649
Total Stockholder Equity88,610
Total Current Liabilities
Accounts payable 8,717
Total Current Liabilities  (as reported)18,177
Total Current Liabilities  (calculated)8,717
+/- 9,460
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt973
Long-term Liabilities  (as reported)649
Long-term Liabilities  (calculated)973
+/- 324
Total Stockholder Equity
Total Stockholder Equity (as reported)88,610
Total Stockholder Equity (calculated)0
+/- 88,610
Other
Capital Stock3
Common Stock Shares Outstanding 33,421
Net Invested Capital 88,610
Net Working Capital 88,445
Property Plant and Equipment Gross 853



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
55,221
95,321
171,304
162,943
154,024
144,412
133,608
122,504
108,182
98,868
148,039
130,388
107,436
107,436130,388148,03998,868108,182122,504133,608144,412154,024162,943171,30495,32155,221000
   > Total Current Assets 
0
0
0
55,025
93,560
171,141
162,665
153,734
142,715
132,011
120,998
106,353
97,018
146,320
128,772
106,622
106,622128,772146,32097,018106,353120,998132,011142,715153,734162,665171,14193,56055,025000
       Cash And Cash Equivalents 
0
0
0
53,613
91,221
140,368
126,409
124,660
121,094
118,264
62,132
19,927
30,395
9,081
11,737
27,632
27,63211,7379,08130,39519,92762,132118,264121,094124,660126,409140,36891,22153,613000
       Short-term Investments 
0
0
0
0
0
26,963
31,325
23,010
17,568
8,588
53,948
81,246
63,392
133,596
113,877
75,331
75,331113,877133,59663,39281,24653,9488,58817,56823,01031,32526,96300000
       Other Current Assets 
0
0
0
1,412
2,339
3,810
4,931
6,064
4,053
5,159
4,918
5,180
3,231
3,643
3,158
3,659
3,6593,1583,6433,2315,1804,9185,1594,0536,0644,9313,8102,3391,412000
   > Long-term Assets 
0
0
0
196
1,761
163
278
290
1,697
1,597
1,506
1,829
1,850
1,719
1,616
814
8141,6161,7191,8501,8291,5061,5971,6972902781631,761196000
       Property Plant Equipment 
0
0
0
69
81
85
200
212
1,619
1,519
1,427
1,745
1,769
1,640
1,535
733
7331,5351,6401,7691,7451,4271,5191,619212200858169000
       Other Assets 
0
0
0
0
1,680
78
78
78
78
78
79
0
0
79
0
0
0079007978787878781,6800000
> Total Liabilities 
0
0
0
97,336
144,038
3,753
6,735
6,813
9,094
9,451
10,459
8,212
11,784
15,511
15,444
18,826
18,82615,44415,51111,7848,21210,4599,4519,0946,8136,7353,753144,03897,336000
   > Total Current Liabilities 
0
0
0
4,580
3,930
3,336
6,353
6,202
7,910
8,335
9,450
7,124
10,481
13,738
13,563
18,177
18,17713,56313,73810,4817,1249,4508,3357,9106,2026,3533,3363,9304,580000
       Short-term Debt 
0
0
0
0
0
0
0
0
457
408
410
404
363
318
325
0
032531836340441040845700000000
       Accounts payable 
0
0
0
908
556
434
1,271
2,022
1,566
1,560
2,189
1,893
1,802
1,828
2,473
8,717
8,7172,4731,8281,8021,8932,1891,5601,5662,0221,271434556908000
       Other Current Liabilities 
0
0
0
3,672
3,374
2,902
5,082
4,180
5,887
6,367
6,851
4,827
8,316
11,592
10,765
0
010,76511,5928,3164,8276,8516,3675,8874,1805,0822,9023,3743,672000
   > Long-term Liabilities 
0
0
0
92,756
140,108
417
382
611
1,184
1,116
1,009
1,088
1,303
1,773
1,881
649
6491,8811,7731,3031,0881,0091,1161,184611382417140,10892,756000
       Warrants
0
0
0
0
140,076
0
0
0
0
0
0
0
0
0
0
0
00000000000140,0760000
       Other Liabilities 
0
0
0
0
32
417
382
611
57
55
66
29
0
876
0
0
00876029665557611382417320000
       Deferred Long Term Liability 
0
0
0
0
32
417
382
0
0
55
66
29
324
0
0
0
00032429665500382417320000
> Total Stockholder Equity
0
0
0
-42,115
-48,717
167,551
156,208
147,211
135,318
124,157
112,045
99,970
87,084
132,528
114,944
88,610
88,610114,944132,52887,08499,970112,045124,157135,318147,211156,208167,551-48,717-42,115000
   Common Stock
0
0
0
0
0
3
3
3
3
3
3
3
3
3
3
0
0333333333300000
   Retained Earnings Total Equity000-151,790-136,683-123,083-110,07600-74,121-61,386-52,1700000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
5
17
34
64
168
-26
-43
12
-31
-21
0
0-21-3112-43-26168643417500000
   Capital Surplus 
0
0
0
0
3,453
228,929
230,309
0
0
234,062
235,151
236,693
238,859
0
0
0
000238,859236,693235,151234,06200230,309228,9293,4530000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
0
0
2,843
-42,199
57,625
67,366
231,902
233,015
234,062
235,151
236,693
238,859
303,877
305,479
0
0305,479303,877238,859236,693235,151234,062233,015231,90267,36657,625-42,1992,843000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-83,053
Operating Income-83,053-83,053
 
Operating Expense (+$)
Research Development56,613
Selling General Administrative26,440
Selling And Marketing Expenses0
Operating Expense83,05383,053
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-83,053
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-77,388-88,718
EBIT - interestExpense = 0
-77,388
-77,388
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-77,388
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-77,388
Tax Provision-0
Net Income From Continuing Ops-77,388-77,388
Net Income-77,388
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net5,6650
 

Technical Analysis of Reneo Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Reneo Pharmaceuticals Inc. The general trend of Reneo Pharmaceuticals Inc is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Reneo Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Reneo Pharmaceuticals Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.74 < 1.79 < 1.79.

The bearish price targets are: 1.63 > 1.58 > 1.565.

Tweet this
Reneo Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Reneo Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Reneo Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Reneo Pharmaceuticals Inc. The current macd is 0.00534488.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Reneo Pharmaceuticals Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Reneo Pharmaceuticals Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Reneo Pharmaceuticals Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Reneo Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartReneo Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Reneo Pharmaceuticals Inc. The current adx is 16.96.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Reneo Pharmaceuticals Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Reneo Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Reneo Pharmaceuticals Inc. The current sar is 2.29990242.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Reneo Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Reneo Pharmaceuticals Inc. The current rsi is 45.50. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Reneo Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartReneo Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Reneo Pharmaceuticals Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Reneo Pharmaceuticals Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Reneo Pharmaceuticals Inc Daily Stochastic Oscillator ChartReneo Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Reneo Pharmaceuticals Inc. The current cci is 4.26849137.

Reneo Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartReneo Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Reneo Pharmaceuticals Inc. The current cmo is -14.01245179.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Reneo Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartReneo Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Reneo Pharmaceuticals Inc. The current willr is -77.69516729.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Reneo Pharmaceuticals Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Reneo Pharmaceuticals Inc Daily Williams %R ChartReneo Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Reneo Pharmaceuticals Inc.

Reneo Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Reneo Pharmaceuticals Inc. The current atr is 0.06348727.

Reneo Pharmaceuticals Inc Daily Average True Range (ATR) ChartReneo Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Reneo Pharmaceuticals Inc. The current obv is -14,549,470.

Reneo Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartReneo Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Reneo Pharmaceuticals Inc. The current mfi is 54.56.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Reneo Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartReneo Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Reneo Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Reneo Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Reneo Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.495
Ma 20Greater thanMa 501.684
Ma 50Greater thanMa 1001.658
Ma 100Greater thanMa 2002.480
OpenGreater thanClose1.710
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Reneo Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Reneo Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Reneo Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Reneo Pharmaceuticals Inc

I send you an email if I find something interesting about Reneo Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Reneo Pharmaceuticals Inc.

Receive notifications about Reneo Pharmaceuticals Inc in your mailbox!